Anja Schmall

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
No aliases are listed.
Publication record
24 papers · 698 citations · H-index 8

PAPERS

Real-world safety and effectiveness of radium-223 (223Ra) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated in the US: The non-interventional REASSURE study.
20230 citationsauthor #9
177Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior 223Ra (RALU Study)
202312 citationsauthor #13
Time interval between radium-223 (223Ra) therapy and Lutetium-177–prostate-specific membrane antigen (177Lu-PSMA) treatment and outcomes in the RALU study.
20231 citationsauthor #13
Safety and Survival Outcomes of 177 Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior 223 Ra treatment: The RALU Study
20238 citationsauthor #13
Safety and Survival Outcomes of 177Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior 223Ra treatment: The RALU Study
202228 citationsauthor #13
Real-world effectiveness, long-term safety and treatment pathway integration of radium-223 therapy in patients with metastatic castration-resistant prostate cancer
20229 citationsauthor #7
Progression patterns by types of metastatic spread, prostate-specific antigen (PSA), and clinical symptoms: Post-hoc analyses of ARAMIS.
20223 citationsauthor #8
Safety and Survival Outcomes of Lutetium-177–Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with prior Radium-223 treatment: The RALU Study
20221 citationsauthor #15
MP27-05 EFFICACY AND SAFETY OF DAROLUTAMIDE IN NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS WITH AND WITHOUT PRIOR LOCAL THERAPY WITH RADICAL PROSTATECTOMY OR RADIOTHERAPY
20221 citationsauthor #6
Microenvironmental Th9- and Th17- lymphocytes induce metastatic spreading in lung cancer.
2020127 citationsauthor #14
Circulating Fibrocytes Depletion Results In Reduced Lung Tumor Growth And Metastasis By Modulating Macrophage Phenotype, Angiogenesis And Endothelin System
20170 citationsauthor #4
FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis
201798 citationsauthor #3
Abstract 1594: Contribution of Stromal Lymphocytes to Lung Cancer Metastasis: Role in Epithelial Mesenchymal Transition
20160 citationsauthor #3
Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer.
2015217 citationsauthor #1
Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF
2013139 citationsauthor #3
Endotoxin induces proliferation of NSCLC in vitro and in vivo
20130 citationsauthor #14
Abstract 2604: Involvement of circulating fibrocytes in the progression of adenocarcinomas by modulating EMT and tumor microenvironment.
20130 citationsauthor #3
The effect of endotoxin on cell-proliferation and responsiveness to treatment in Non-small-cell-lung-cancer
20120 citationsauthor #5
Phosphodiesterase 4 Regulates Lung Tumor Growth Through HIF Regulation, Proliferation, And Angiogenesis
20120 citationsauthor #3
Abstract 1839: Phosphodiesterase 4 regulates lung tumor growth through HIF regulation, proliferation, and angiogenesis
20120 citationsauthor #3
The role of Forkhead Box O 3a (FoxO3a) Transcription Factors in the Pathogenesis of Pulmonary Fibrosis
20120 citationsauthor #3
Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation
201254 citationsauthor #5
Abstract 1484: Functional and molecular characterization of macrophage-tumor cell communication
20120 citationsauthor #1
Functional and molecular characterization of macrophage-tumor cell communication
20120 citationsauthor #1

TIMELINE

2012 54 citations

2013 139 citations

2015 217 citations

2016 0 citations

2017 98 citations

2020 127 citations

2022 42 citations

2023 21 citations

Anja Schmall

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT